INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined garlic. Clear

Pooled results from many studies on one question.

10 studies

2019 / Systematic review and meta-analysis

In patients with diabetes, garlic intake significantly improved lipid parameters, fasting blood sugar, and HbA1C compared to placebo.

A systematic review and meta-analysis of 33 studies evaluated the effects of garlic compared with placebo in 1,273 individuals with diabetes. Garlic was associated with significant decreases in total cholesterol by 16.87 mg/dl (95% CI, -21.01 to -12.73; P=0.001), LDL by 9.65 mg/dl (95% CI, -15.07 to -4.23; P=0.001), triglycerides by 12.44 mg/dl (95% CI, -18.19 to -6.69; P=0.001), fasting blood sugar by 10.90 mg/dl (95% CI, -16.40 to -5.40; P=0.001), and HbA1C by 0.60 mg/dl (95% CI, -0.98 to -0.22; P=0.001). Serum HDL significantly increased by 3.19 mg/dl (95% CI, 1.85 to 4.53; P=0.001).

Shabani E, Sayemiri K, Mohammadpour M Prim Care Diabetes, 2019. PMID 30049636

2019 / Systematic review and meta-analysis of randomized controlled trials

Garlic supplementation significantly reduced serum C-reactive protein levels in a meta-analysis of randomized controlled trials.

A systematic review and meta-analysis of nine randomized controlled trials with a total sample size of 363 evaluated the effects of garlic supplementation on serum C-reactive protein (CRP) levels. Compared with controls, garlic intake significantly reduced serum CRP concentrations by 0.8 mg/L (95% CI [-1.5, -0.1], p = 0.02), with evidence of heterogeneity among studies. Subgroup analyses showed significant reductions of 0.82 mg/L (95% CI [-1.02, -0.62], p < 0.001) in trials with doses ≥1,200 mg/day and 2.44 mg/L (95% CI [-4.02, -0.87], p = 0.002) in trials with baseline CRP ≥2 mg/L.

Taghizadeh M, Hamedifard Z, Jafarnejad S Phytother Res, 2019. PMID 30370629

2019 / Meta-analysis of randomized controlled trials

Garlic supplementation reduced circulating inflammatory markers CRP, IL-6, and TNF in adults.

A meta-analysis of 16 randomized controlled trials evaluated garlic doses between 12 and 3,600 mg daily for 2 to 52 weeks. Garlic administration lowered serum C-reactive protein (WMD -0.61 mg/L, 95% CI -1.12 to -0.11), IL-6 (WMD -0.73 ng/L, 95% CI -1.06 to -0.40), and TNF (WMD -0.26 ng/L, 95% CI -0.41 to -0.12). Conversely, garlic exerted no significant effect on adiponectin or leptin levels.

Darooghegi Mofrad M, Milajerdi A, Koohdani F, et al. J Nutr, 2019. PMID 30949665

2018 / Systematic review

Evidence for superfood effects on metabolic syndrome risk factors remains limited

A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.

van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436

2016 / Updated meta-analysis and review of randomized controlled trials

Garlic preparations reduced systolic and diastolic blood pressure, with larger reductions seen in hypertensive individuals.

Researchers updated a meta-analysis of randomized controlled trials evaluating the effect of garlic preparations on blood pressure and reviewed its effects on cholesterol and immunity. In 20 trials with 970 participants, garlic decreased systolic blood pressure by a mean ± SE of 5.1 ± 2.2 mm Hg (P < 0.001) and diastolic blood pressure by 2.5 ± 1.6 mm Hg (P < 0.002) compared with placebo. In trials of hypertensive subjects, reductions were larger: 8.7 ± 2.2 mm Hg for SBP (P < 0.001; n = 10) and 6.1 ± 1.3 mm Hg for DBP (P < 0.001; n = 6). A previously published meta-analysis cited in the review noted a 10% reduction in total and LDL cholesterol when taken for >2 months by individuals with slightly elevated levels, and clinical trials showed reductions in upper respiratory infections.

Ried K J Nutr, 2016. PMID 26764326

2015 / Case-control study and meta-analysis of observational studies

Higher intake of allium vegetables, garlic, and onions was linked to lower gastric cancer risk, an association driven mainly by case-control studies.

Researchers evaluated allium vegetable intake and gastric cancer risk using an Italian case-control study (230 cases, 547 controls) and a meta-analysis (>10,000 cases). In the case-control study, odds ratios were 0.59 (95% CI, 0.25-1.41) for ≥2 portions of onion per week, 0.69 (95% CI, 0.41-1.15) for high garlic intake, and 0.70 (95% CI, 0.39-1.28) for frequent use of both. In the meta-analysis, pooled relative risks for highest versus lowest intake were 0.78 (95% CI, 0.67-0.91) for allium vegetables, 0.60 (95% CI, 0.47-0.76) for garlic, and 0.55 (95% CI, 0.41-0.73) for onion. However, the pooled relative risk for high allium vegetable intake from the four cohort studies was 1.02 (95% CI, 0.88-1.18), with authors noting further data from large cohorts are desirable.

Shows an association, not proof of cause and effect.

Turati F, Pelucchi C, Guercio V, et al. Mol Nutr Food Res, 2015. PMID 25215621

2015 / Meta-analysis of case-control, cohort, and randomized studies

Garlic intake was associated with a reduced risk of gastric cancer.

A meta-analysis of 14 case-control, two randomized, and one cohort study assessed garlic intake and gastric cancer risk among 8,621 cases and 14,889 controls. High garlic consumption was associated with lower gastric cancer risk (OR 0.49, 95% CI 0.38-0.62), as were low intake (OR 0.75, 95% CI 0.58-0.97) and any intake (OR 0.77, 95% CI 0.60-1.00). Substantial variation was observed in intake duration and exposure definitions across studies.

Kodali RT, Eslick GD Nutr Cancer, 2015. PMID 25411831

2015 / Meta-analysis of randomized controlled trials

Garlic supplementation lowered systolic and diastolic blood pressure in hypertensive patients.

A meta-analysis evaluated 7 randomized placebo-controlled trials investigating garlic for blood pressure management in hypertensive patients. Compared to placebo, garlic significantly decreased systolic blood pressure (WMD: -6.71 mmHg; 95% CI: -12.44 to -0.99; P = 0.02) and diastolic blood pressure (WMD: -4.79 mmHg; 95% CI: -6.60 to -2.99; P < 0.00001). No serious adverse events were documented across the trials.

Xiong XJ, Wang PQ, Li SJ, et al. Phytomedicine, 2015. PMID 25837272

2014 / Systematic review of randomized controlled trials

Clinical trial evidence is insufficient to confirm garlic prevents or treats colds.

A systematic review identified only one eligible trial evaluating garlic supplementation for the common cold. That study randomized 146 participants to daily garlic or placebo for 12 weeks, finding fewer colds in the garlic arm (24 versus 65, P < 0.001) and fewer sick days (111 versus 366). Days to recovery were comparable (4.63 versus 5.63 days), leaving insufficient evidence to draw firm conclusions.

Lissiman E, Bhasale AL, Cohen M Cochrane Database Syst Rev, 2014. PMID 25386977

2013 / Meta-analysis of trials

Garlic preparations reduced total and LDL cholesterol in individuals with elevated levels.

A meta-analysis of 39 primary trials investigated the lipid effects of garlic preparations. In individuals with total cholesterol above 200 mg/dL, treatment for more than 2 months reduced total cholesterol by 17 ± 6 mg/dL and LDL cholesterol by 9 ± 6 mg/dL. HDL cholesterol rose only slightly, whereas triglycerides showed no significant alteration.

Ried K, Toben C, Fakler P Nutr Rev, 2013. PMID 23590705